A detailed history of Cooper Investors Pty LTD transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Cooper Investors Pty LTD holds 137,605 shares of STVN stock, worth $3.45 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
137,605
Previous 112,384 22.44%
Holding current value
$3.45 Million
Previous $2.45 Billion 14.74%
% of portfolio
0.46%
Previous 0.39%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025

BUY
$18.11 - $24.11 $456,752 - $608,078
25,221 Added 22.44%
137,605 $2.81 Billion
Q4 2024

Apr 10, 2025

BUY
$17.27 - $23.67 $474,562 - $650,427
27,479 Added 32.36%
112,384 $2.45 Billion
Q2 2024

Apr 10, 2025

BUY
$16.93 - $31.33 $1.44 Million - $2.66 Million
84,905 New
84,905 $1.56 Billion
Q1 2024

Apr 09, 2025

SELL
$25.34 - $34.28 $1.91 Million - $2.58 Million
-75,299 Closed
0 $0
Q4 2023

Apr 09, 2025

BUY
$25.21 - $34.66 $403,360 - $554,560
16,000 Added 26.98%
75,299 $2.05 Billion
Q3 2023

Apr 09, 2025

BUY
$26.91 - $35.49 $191,061 - $251,979
7,100 Added 13.6%
59,299 $1.92 Billion
Q1 2023

Apr 09, 2025

BUY
$17.5 - $25.9 $494,970 - $732,555
28,284 Added 118.27%
52,199 $1.35 Billion
Q4 2022

Apr 09, 2025

BUY
$13.95 - $19.28 $25,110 - $34,704
1,800 Added 8.14%
23,915 $430 Million
Q3 2022

Apr 14, 2025

SELL
$14.66 - $18.3 $1.32 Million - $1.65 Million
-90,269 Reduced 80.32%
22,115 $375 Million
Q2 2022

Apr 09, 2025

BUY
$14.1 - $20.26 $19,740 - $28,364
1,400 Added 6.76%
22,115 $350 Million
Q1 2022

Apr 08, 2025

BUY
$15.23 - $21.47 $235,364 - $331,797
15,454 Added 293.75%
20,715 $417 Million
Q4 2021

Apr 08, 2025

BUY
$21.65 - $27.0 $113,900 - $142,047
5,261 New
5,261 $118 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $6.64B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Cooper Investors Pty LTD Portfolio

Follow Cooper Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Investors Pty LTD with notifications on news.